Anabolic androgenic steroid abuse: Multiple mechanisms of regulation of GABAergic synapses in neuroendocrine control regions of the rodent forebrain

Journal of Neuroendocrinology

Volumn 24, Issue 1, 2012, Pages 202-214

  Oberlander, J G ^a   Porter, D M ^a   Penatti, C A A ^b   Henderson, L P ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Adolescence; Anabolic steroids; GABA A receptor; GnRH; Kisspeptin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANABOLIC ANDROGENIC STEROID; ANDROGEN; ANDROGEN RECEPTOR; ESTRADIOL; FOLLITROPIN; FORMESTANE; GABAERGIC RECEPTOR AFFECTING AGENT; GONADORELIN; LUTEINIZING HORMONE; METHYLTESTOSTERONE; NEUROSTEROID; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ALLOSTERISM; ATHLETIC PERFORMANCE; AWARENESS; BODY IMAGE; CELL FUNCTION; DRUG ABUSE; DRUG EXPOSURE; DRUG MEGADOSE; FOLLITROPIN BLOOD LEVEL; FOREBRAIN; HUMAN; IN VITRO STUDY; LIBIDO DISORDER; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; NERVE CELL; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; SEXUAL BEHAVIOR; SIDE EFFECT; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TESTIS ATROPHY; TRANQUILIZING ACTIVITY; WILD TYPE;

ANABOLIC AGENTS; ANDROGENS; ANIMALS; GAMMA-AMINOBUTYRIC ACID; MICE; NEURONS; PROSENCEPHALON; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84055188803     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02151.x     Document Type: Review

References (140)

1. Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001; 86: 5108-5117.
2. Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 2001; 23: 1355-1390.
3. Kochakian C, Yesalis CE. Anabolic-androgenic steroids: a historical perspective and definition. In: Yesalis CE, ed. Anabolic Steroids in Sport and Exercise. Champaign, IL: Human Kinetics, 2000: 4-33.
4. Llewellyn W. Anabolics. 6th edn, Jupiter, FL: Body of Science, 2007; vii-ix.
5. Trenton AJ, Currier GW. Behavioural manifestations of anabolic steroid use. CNS Drugs 2005; 19: 571-595.
6. Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 2008; 2: 1-12.
7. Wu FC. Endocrine aspects of anabolic steroids. Clin Chem 1997; 43: 1289-1292.
8. Daly RC, Su TP, Schmidt PJ, Pickar D, Murphy DL, Rubinow DR. Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry 2001; 58: 172-177.
9. Perry PJ, Kutscher EC, Lund BC, Yates WR, Holman TL, Demers L. Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. J Forensic Sci 2003; 48: 1-6.
10. Matsumoto AM, Bremner WJ. Serum testosterone assays - accuracy matters. J Clin Endocrinol Metab 2004; 89: 520-524.
11. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43: 1262-1279.
12. Bahrke MS, Yesalis CE, Kopstein AN, Stephens JA. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med 2000; 29: 397-405.
13. Miller KE, Hoffman JH, Barnes GM, Sado D, Melnick MJ, Farrell MP. Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors. Subst Use Misuse 2005; 40: 1637-1657.
14. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use, 1975-2008. Volume I: Secondary School Students (NIH Publication No. 09-7402). Bethesda, MD: National Institute on Drug Abuse, 2009: 721.
15. Bahrke MS, Yesalis CE, Brower KJ. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. Child Adolesc Psychiatr Clin N Am 1998; 7: 821-838.
16. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24: 417-463.
17. Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nat Neurosci 2004; 7: 1040-1047.
18. Sato SM, Schulz KM, Sisk CL, Wood RI. Adolescents and androgens, receptors and rewards. Horm Behav 2008; 53: 647-658.
19. Field AE, Austin SB, Carmargo CA, Taylor CB, Stiegel-Moore RH, Loud KJ, Colditz GA. Exposure to mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents. Pediatrics 2005; 116: 214-220.
20. O'Connor LH, Cicero TJ. Anabolic steroids: misuse or abuse? In: Schulkin J, ed. Hormonally Induced Changes in Mind and Brain. Orlando, FL: Academic Press, 1993: 129-156.
21. Gallaway S. The Steroid Bible, 3rd edn. Honolulu: Belle International, 1997.
22. Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry 2006; 21: 551-562.
23. Martini L. The 5α-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications. Endocr Rev 1982; 3: 1-25.
24. Winters SJ. Androgens: endocrine physiology and pharmacology. NIDA Res Monogr 1990; 102: 113-130.
25. Ryan KJ. Biological aromatization of steroids. J Biol Chem 1959; 234: 268-272.
26. 3H]17α-methyltestosterone in human subjects. J Endocrinol 1967; 37: 37-55.
27. Papaconstantinou AD, Umbreit TH, Goering PL, Brown KM. Effects of 17α-methyltestosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors. J Steroid Biochem Mol Biol 2002; 82: 305-314.
28. de Gooyer ME, Oppers-Tiemissen HM, Leysen D, Verheul HA, Kloosterboer HJ. Tibolone is not converted by human aromatase to 7α-methyl-17α-ethynylestradiol (7α-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 2003; 68: 235-243.
29. Saartok T, Dahlberg E, Gustafsson JA. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology 1984; 114: 2100-2106.
30. Roselli C. The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area. Brain Res 1998; 792: 271-276.
31. Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure. Steroid 2009; 74: 172-197.
32. Dimick DF, Heron M, Baulieu EE, Jayle MF. A comparative study of the metabolic fate of testosterone, 17α-methyltestosterone, 19-nor-testosterone, 17α-methyl-19-nor-tesosterone and 17α-methyl-estr-5(10)-ene-17β-ol-3-one in normal males. Clin Chim Acta 1961; 6: 63-71.
33. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem 1996; 42: 1001-1020.
34. Fragkaki AG, Angelis YS, Tsantili-Kakoulidou A, Koupparis M, Georgakopoulos C. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine. J Steroid Biochem Mol Biol 2009; 115: 44-61.
35. Whitney AC, Clark AS. Effects of acute stanozolol treatment on puberty in female rats. Biol Reprod 2001; 64: 1460-1465.
36. Pinna G, Costa E, Guidotti A. Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc Natl Acad Sci USA 2005; 102: 2135-2140.
37. Penatti CAA, Costine BA, Porter DM, Henderson LP. Effects of chronic exposure to an anabolic androgenic steroid cocktail on α5-receptor mediated GABAergic transmission and neural signaling in the forebrain of female mice. Neuroscience 2009; 161: 526-537.
38. Kurling-Kailanto S, Kankaanpää A, Hautaniemi J, Seppälä T. Blockade of androgen or estrogen receptors reduces nandrolone's ability to modulate acute reward-related neurochemical effects of amphetamine in rat brain. Pharmacol Biochem Behav 2010; 95: 422-427.
39. Attardi BJ, Hild SA, Reel JR. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. Endocrinology 2006; 147: 3016-3026.
40. Attardi BJ, Page ST, Hild SA, Coss CC, Matsumoto AM. Mechanism of action of bolandiol (19-nortestosterone-3β, 17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities. J Steroid Biochem Mol Biol 2010; 118: 151-161.
41. A receptor. Neurosci Lett 1995; 189: 35-38.
42. 35S TBPS binding. J Pharmacol Exp Ther 1996; 279: 186-193.
43. Lund TD, Hinds LR, Handa RJ. The androgen 5α-dihydrotestosterone and its metabolite 5α-androstan-3β, 17β-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor β-expressing neurons in the hypothalamus. J Neurosci 2006; 26: 1448-1456.
44. Pak TR, Chung WCJ, Hinds LR, Handa RJ. Estrogen receptor-β mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells. Endocrinology 2007; 148: 3371-3382.
45. Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L. An alternative pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5α-androstane-3β, 17β-diol. Horm Behav 2008; 53: 741-752.
46. Handa RJ, Weiser MJ, Zuloaga DG. A role for the androgen metabolite, 5α-androstane-3β, 17β-diol in modulating oestrogen receptor β-mediated regulation of hormonal stress reactivity. J Neuroendocrinol 2009; 21: 351-358.
47. Luzardo OP, Machín RP, Díaz-Chico BN, Fernández L. Photoaffinity labeling identification of a specific binding protein for the anabolic steroids stanozolol and danazol: an oligomeric protein regulated by age, pituitary hormones, and ethinyl estradiol. Endocrinology 2000; 141: 3377-3387.
48. A receptor mediated-behaviors. In: Smith SS, ed. Neurosteroid Effects in the Central Nervous System: The Role of the GABAA Receptor. Boca Raton, FL: CRC Press LLC, 2004: 119-141.
49. Clark AS, Costine BA, Jones BL, Kelton-Rehkopf MC, Meerts SH, Nutbrown-Greene LL, Penatti CAA, Porter DM, Yang P, Henderson LP. Sex- and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res 2006; 1126: 122-138.
50. A receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 2007; 52: 1439-1453.
51. Lu S-F, McKenna SE, Cologer-Clifford A, Nau EA, Simon NG. Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology 1998; 139: 1594-1601.
52. Shah NM, Pisapia DJ, Maniatis S, Mendelsohn MM, Nemes A, Axel R. Visualizing sexual dimorphism in the brain. Neuron 2004; 43: 313-319.
53. Kudwa AE, Gustafsson J-Å, Rissman EF. Estrogen receptor β modulates estradiol induction of progestin receptor immunoreactivity in male, but not in female, mouse medial preoptic area. Endocrinology 2004; 145: 4500-4506.
54. Brussaard AB, Wossink J, Lodder JC, Kits KS. Progesterone-metabolite prevents protein kinase C-dependent modulation of γ-aminobutyric acid type A receptors in oxytocin neurons. Proc Natl Acad Sci USA 2000; 97: 3625-3630.
55. Tasker J. Coregulation of ion channels by neurosteroids and phosphorylation. Sci STKE. 2000 Nov 21;2000(59):pe1.
56. Fáncsik A, Linn DM, Tasker JG. Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J Neurosci 2000; 20: 3067-3075.
57. A receptors in supraoptic nucleus around parturition. J Neurosci 2003; 23: 788-797.
58. Widmer H, Ludwig M, Bancel F, Leng G, Dayanithi G. Neurosteroid regulation of oxytocin and vasopressin release from the rat supraoptic nucleus. J Physiol (Lond) 2003; 1: 233-244.
59. Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000; 69: 19-26.
60. Clark AS, Henderson LP. Behavioral and physiological responses to anabolic androgenic steroids. Neurosci Biobehav Rev 2003; 27: 413-436.
61. Lukas SE. Current perspectives on anabolic-androgenic steroid abuse. Trends Pharmacol Sci 1993; 14: 61-68.
62. Kam PCA, Yarrow M. Anabolic steroid abuse: physiological and anaesthetic considerations. Anaesthesia 2005; 60: 685-692.
63. Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 1985; 253: 2871-2873.
64. Elliot DL, Goldberg L. Women and anabolic steroids. In: Yesalis CE, ed. Anabolic Steroids in Sport and Exercise. Champaign, IL: Human Kinetics, 2000: 225-246.
65. Kraulis I, Naish SJ, Gravenor D, Ruf KB. 5α-androstane-3α, 17β diol: inhibitor of sexual maturation in the female rat. Biol Reprod 1981; 24: 445-453.
66. Kramer P, Meijs-Roelofs HMA. Retardation of first ovulation in pubertal rats after treatment with 5α-androstane-3α, 17β-diol of its 3β-epimer. J Endocrinol 1982; 92: 31-35.
67. A receptor subunit mRNAs in the mouse forebrain. Neuropharmacology 2002; 43: 634-645.
68. Wesson DW, McGinnis MY. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment. Pharmacol Biochem Behav 2006; 83: 410-419.
69. A receptor-mediated synaptic transmission disrupts the firing of gonadotropin-releasing hormone neurons in male mice under conditions of steroid abuse. J Neurosci 2010; 30: 6497-6506.
70. Clark AS, Kelton MC, Whitney AC. Chronic administration of anabolic steroids disrupts pubertal onset and estrous cyclicity in rats. Biol Reprod 2003; 68: 465-471.
71. Penatti CAA, Oberlander JG, Davis MC, Porter DM, Henderson LP. Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse. Neuropharmacology 2011; (in press).
72. Bronson FH. Effects of prolonged exposure to anabolic steroid on the behavior of male and female mice. Pharmacol Biochem Behav 1996; 53: 329-334.
73. Clark AS, Harrold EV, Fast AS. Anabolic-androgenic steroid effects on the sexual behavior of intact male rats. Horm Behav 1997; 31: 35-46.
74. Bronson FH, Nguyen KQ, De La Rosa J. Effect of anabolic steroids on behavior and physiological characteristics of female mice. Physiol Behav 1996; 59: 49-55.
75. Blasberg ME, Clark AS. Anabolic-androgenic steroid effects on sexual receptivity in ovariectomized rats. Horm Behav 1997; 32: 201-208.
76. Salas-Ramirez KY, Montalto PR, Sisk CL. Anabolic androgenic steroids differentially affect social behaviors in adolescent and adult male Syrian hamsters. Horm Behav 2008; 53: 378-385.
77. Newman SW. The medial extended amygdala in male reproductive behavior. A node in the mammalian social behavior network. Ann NY Acad Sci 1999; 877: 242-257.
78. Blaustein JD, Erskine MS. Feminine sexual behavior: cellular integration of hormonal and afferent information in the rodent forebrain. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT, eds. Hormones, Brain and Behavior, Vol 1. Orlando, FL: Academic Press, 2002: 139-213.
79. Hull EM, Meisel RL, Sachs BD. Male sexual behavior. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT, eds. Hormones, Brain and Behavior, Vol 1. Orlando, FL: Academic Press, 2002: 3-137.
80. Ojeda SR, Lomniczi A, Mastronardi C, Heger S, Roth C, Parent A-S, Matagne V, Mungenast AE. Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach? Endocrinology 2006; 147: 1166-1174.
81. Herbison AE. Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: the case for the rostral periventricular area of the third ventricle (RPV3). Brain Res Rev 2008; 57: 277-287.
82. Christian CA, Moenter SM. The neurobiology of preovulatory and estradiol-induced gonadotropin releasing hormone surges. Endocr Rev 2010; 31: 544-577.
83. A receptors. J Physiol (Lond) 2006; 573: 571-593.
84. Penatti CAA, Porter DM, Henderson LP. Chronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor- and estrogen receptor-mediated mechanisms. J Neurosci 2009; 29: 12484-12496.
85. A receptor expression and function in adolescent mice. Neuroscience 2005; 135: 533-543.
86. A receptors. Neuropharmacology 2002; 43: 619-633.
87. A receptors by anabolic androgenic steroids. Neuropharmacology 2005; 49: 300-316.
88. Whiting PJ, Bonnert TP, McKernan RM, Farrar S, Le Bourdelles B, Heavens RP, Smith DW, Hewson L, Rigby MR, Sirinathsinghji DJ, Thompson SA, Wafford KA. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann NY Acad Sci 1999; 868: 645-653.
89. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12: 1040-1062.
90. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995; 359: 154-194.
91. A receptor immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000; 101: 815-850.
92. A receptor subunits α1 and α2 in the hypothalamus and limbic system of the rat. Dev Brain Res 2000; 119: 127-138.
93. A receptors in neurons expressing γ1 subunit mRNA in the preoptic area of the rat. J Neurophysiol 1999; 81: 192-203.
94. A receptor signalling in native GnRH neurons. Eur J Neurosci 2000; 12: 3497-3504.
95. Suter KJ, Song WJ, Sampson TL, Wuarin JP, Saunders JT, Dudek FE, Moenter SM. Genetic targeting of green fluorescent protein to gonadotropin-releasing hormone neurons: characterization of whole-cell electrophysiological properties and morphology. Endocrinology 2000; 141: 412-419.
96. A receptor ε results in insensitivity to anaesthetics. Neuropharmacology 2002; 43: 662-668.
97. A receptors. J Neurochem 2007; 103: 1258-1271.
98. Moragues N, Ciofi P, Lafon P, Odessa MF, Tramu G, Garret M. cDNA cloning and expression of a γ-aminobutyric acid A receptor ε-subunit in rat brain. Eur J Neurosci 2000; 12: 4318-4330.
99. A receptor ε subunit expression in identified peptidergic neurons of the rat hypothalamus. Brain Res 2003; 967: 285-289.
100. A receptor ε-subunit in cholinergic and aminergic neruones and evidence for co-distribution with the θ-subunit in rat brain. Neuroscience 2002; 111: 657-669.
101. A receptor ε and θ subunits display unusual structural variation between species and are enriched in the rat locus ceruleus. J Neurosci 2000; 20: 3588-3595.
102. A receptor function. Trends Pharmacol Sci 1995; 16: 295-303.
103. A receptors. Prog Neurobiol 2003; 71: 67-80.
104. Belelli D, Herd MB, Mitchell EA, Peden DR, Vardy AW, Gentet L, Lambert JJ. Neuroactive steroids and inhibitory neurotransmission: mechanism of action and physiological relevance. Neuroscience 2006; 138: 821-829.
105. A receptors through two discrete transmembrane sites. Nature 2006; 444: 486-489.
106. A receptor. Nat Rev 2005; 6: 565-575.
107. Jones MV, Westbrook GL. The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci 1996; 19: 96-101.
108. A receptor. In: Smith SS, ed. Neurosteroid Effects in the Central Nervous System: The Role of the GABAA Receptor. Boca Raton, FL: CRC Press LLC, 2004: 63-75.
109. A receptors containing the δ subunit. Neuropharmacology 2002; 43: 492-502.
110. A receptors containing the delta subunit. J Neurosci 2002; 22: 1541-1549.
111. A receptors in the rat. Horm Behav 1993; 27: 568-583.
112. Ågren G, Thiblin I, Tirassa P, Lundeberg T, Stenfors C. Behavioural anxiolytic effects of low-dose anabolic androgenic steroid treatment in rats. Physiol Behav 1999; 66: 503-509.
113. Aikey JL, Nyby JG, Anmuth DM, James PJ. Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav 2002; 42: 448-460.
114. Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993; 269: 2760-2764.
115. Bahrke MS, Yesalis CE, Wright JE. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. Sports Med 1996; 22: 367-390.
116. Simerly RB, Swanson LW. Projections of the medial preoptic nucleus: a Phaseolus vulgaris leucoagglutinin anterograde tract-tracing study in the rat. J Comp Neurol 1988; 270: 209-242.
117. Hutton LA, Gu G, Simerly RB. Development of a sexually dimorphic projection from the bed nucleus of the stria terminalis to the anteroventral periventricular nucleus in the rat. J Neurosci 1998; 18: 3003-3013.
118. Scott CJ, Tilbrook AJ, Rawson JA, Clarke IJ. Gonadal steroid receptors in the regulation of GnRH secretion in farm animals. Anim Reprod Sci 2000; 61: 313-326.
119. Grattan DR, Jasoni CL, Liu X, Anderson GM, Herbison AE. Prolactin regulation of gonadotropin-releasing hormone neurons to suppress luteinizing hormone secretion in mice. Endocrinology 2007; 148: 4344-4351.
120. DeFazio RA, Moenter SM. Estradiol feedback alters potassium currents and firing properties of gonadotropin-releasing hormone neurons. Mol Endocrinol 2002; 16: 2255-2265.
121. Han SK, Abraham IM, Herbison AE. Effect of GABA on GnRH neurons switches from depolarization to hyperpolarization at puberty in the female mouse. Endocrinology 2002; 143: 1459-1466.
122. Han SK, Todman MG, Herbison AE. Endogenous GABA release inhibits the firing of adult gonadotropin-releasing hormone neurons. Endocrinology 2004; 145: 495-499.
123. Moenter SM, DeFazio RA. Endogenous γ-aminobutyric acid can excite gonadotropin-releasing hormone neurons. Endocrinology 2005; 146: 5374-5379.
124. Christian CA, Moenter SM. Estradiol induces diurnal shifts in GABA transmission to gonadotropin-releasing hormone neurons to provide a neural signal for ovulation. J Neurosci 2007; 27: 1913-1921.
125. Yin C, Ishii H, Tanaka N, Sakuma Y, Kato M. Activation of A-type γ-aminobutyric acid receptors excites gonadotrophin-releasing hormone neurones isolated from adult rats. J Neuroendocrinol 2008; 20: 566-575.
126. Chen P, Moenter SM. GABAergic transmission to gonadotropin-releasing hormone (GnRH) neurons is regulated by GnRH in a concentration-dependent manner engaging multiple signaling pathways. J Neurosci 2009; 29: 9809-9818.127.
127. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE. Immunolocalization of estrogen receptor β in the mouse brain: comparison with estrogen receptor α. Endocrinology 2003; 144: 2055-2067.
128. Nomura M, Korach KS, Pfaff DW, Ogawa S. Estrogen receptor β (ERβ) protein levels in neurons depend on estrogen receptor α (ERα) gene expression and on its ligand in a brain region-specific manner. Brain Res Mol Brain Res 2003; 110: 7-14.
129. Foidart A, Harada N, Balthazart J. Aromatase-immunoreactive cells are present in mouse brain areas that are known to express high levels of aromatase activity. Cell Tissue Res 1995; 280: 561-574.
130. Herbison AE. Estrogen regulation of GABA transmission in rat preoptic area. Brain Res Bull 1997; 44: 321-326.
131. Mor G, Eliza M, Song J, Wiita B, Chen S, Naftolin F. 17α-Methyltestosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture. J Steroid Biochem Mol Biol 2001; 79: 239-246.
132. Hong Y, Cho M, Yuan YC, Chen S. Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromatase. Biochem Pharmacol 2008; 75: 1161-1169.
133. Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E. Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res 2008; 33: 2035-2040.
134. Mayer C, Acosta-Martinez M, Dubois SL, Wolfe A, Radovick S, Boehm U, Levine JE. Timing and completion of puberty in female mice depend on estrogen receptor α-signaling in kisspeptin neurons. Proc Natl Acad Sci USA 2010; 107: 22693-22698.
135. Scordalakes EM, Shetty SJ, Rissman EF. Roles of estrogen receptor α and androgen receptor in the regulation of neuronal nitric oxide synthase. J Comp Neurol 2002; 453: 336-344.
136. Smith JT, Dungan HM, Stoll EA, Gottsch ML, Braun RE, Eacker SM, Clifton DK, Steiner RA. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology 2005; 146: 2976-2984.
137. Homma T, Sakakibara M, Yamada S, Kinoshita M, Iwata K, Tomikawa J, Kanazawa T, Matsui H, Takatsu Y, Ohtaki T, Matsumoto H, Uenoyama Y, Maeda K, Tsukamura H. Significance of neonatal testosterone sex steroids to defeminize anteroventral periventricular kisspeptin neurons and the GnRH/LH surge system in male rats. Biol Reprod 2009; 81: 1216-1225.
138. Murphy L, O'Shaughnessy PJ. Testicular steroidogenesis in the testicular feminized (Tfm) mouse: loss of 17α-hydroxylase activity. J Endocrinol 1991; 131: 443-449.
139. Scott IS, Bennett MK, Porter-Goff AE, Harrison CJ, Cox BS, Grocock CA, O'Shaughnessy PJ, Clayton RN, Craven R, Furr BJA, Charlton HM. Effects of the gonadotrophin-releasing hormone agonist 'Zoladex' upon pituitary and gonadal function in hypogonadal (hpg) male mice: a comparison with normal male and testicular feminized (tfm) mice. J Mol Endocrinol 1992; 8: 249-258.
140. Goulding EH, Hewitt SC, Nakamura N, Hamilton K, Korach KS, Eddy EM. Ex3αERKO male infertility phenotype recapitulates the αERKO male phenotype. J Endocrinol 2010; 207: 281-288.